Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer
Cancer Treatment Reviews · 2026-03 · 144 · 103111
DOI: 10.1016/j.ctrv.2026.103111 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-03. Verfasst von Anna McCracken und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Toronto Institute of Medical Science, Toronto, Canada. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoadjuvant Therapy, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Toronto Institute of Medical Science, Toronto, Canada.
- Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
- Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada; University of Toronto Department of Medical Biophysics, Toronto, Canada.
- Department of Oncology and Epidemiology, University of Western Ontario, London, Canada.
- University of Toronto Institute of Medical Science, Toronto, Canada; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada; Division of Medical Oncology, Sunnybrook Hea…
- University of Toronto Institute of Medical Science, Toronto, Canada; Division of Neurosurgery, St. Michael's Hospital, University of Toronto, Toronto, Canada. Electronic address: sunit.das@utoronto.ca.
Zitieren
APA
McCracken, A., Grafinger, O. R., Leong, H. S., Lohmann, A. E., Jerzak, K. J., & Das, S. (2026). Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer. Cancer Treatment Reviews, 144, 103111. https://doi.org/10.1016/j.ctrv.2026.103111
Vancouver
McCracken A, Grafinger OR, Leong HS, Lohmann AE, Jerzak KJ, Das S. Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer. Cancer Treatment Reviews. 2026;144:103111. doi:10.1016/j.ctrv.2026.103111
BibTeX
@article{McCracken2026,
author = {McCracken, Anna and Grafinger, Olivia R and Leong, Hon S and Lohmann, Ana Elisa and Jerzak, Katarzyna J and Das, Sunit},
title = {Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {144},
pages = {103111},
doi = {10.1016/j.ctrv.2026.103111}
}
EUVIMED